NJ Bio Inc

Advent-owned Suven Pharma to buy majority stake in NJ Bio for $64 mn

Private equity giant Advent International-owned contract development and manufacturing organization (CDMO) Suven Pharma Saturday said it will acquire a controlling ......

• Sreeja Biswas